SYNOPSYS, INC. (SNPS) FY2026 Q3 P&L / Income Statement
2026-05-01 to 2026-07-31
Revenue by Business Segment
2026-05-01 to 2026-07-31
Swipe to see the full flow
Chart details
SYNOPSYS, INC. (SNPS) FY2026 Q3 P&L / Income Statement
Income statement for 2026-05-01 through 2026-07-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenue
- 2,476,822,000 US dollars
- Total cost of revenue
- 679,388,000 US dollars
- Gross margin
- 1,797,434,000 US dollars
- Total operating expenses
- 1,439,943,000 US dollars
- Operating income
- 357,491,000 US dollars
- Other income (expense), net (calculated)
- 326,431,000 US dollars
- Income before income taxes
- 683,922,000 US dollars
- Provision (benefit) for income taxes
- 138,216,000 US dollars
- Net income
- 545,706,000 US dollars
- Design Automation
- 2,002,971,000 US dollars
- Design IP
- 473,851,000 US dollars
- Research and development
- 719,737,000 US dollars
- Sales and marketing
- 385,889,000 US dollars
- General and administrative
- 176,979,000 US dollars
- Amortization of acquired intangible assets
- 155,174,000 US dollars
- Restructuring charges
- 2,164,000 US dollars
- Loss from discontinued operations, net of income taxes
- 0 US dollars. Reported below-tax contribution to net income.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to SYNOPSYS, INC.: $545.80 M; to noncontrolling interests: −$94.00 K.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
72.6%
Gross profit / revenue
Operating margin
14.4%
Operating profit / revenue
Cash conversion
149.0%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
